The information on this page about Taftrio Tablet – Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Taftrio Tablet is a prescription-only antiretroviral medicine used as part of doctor-prescribed HIV treatment (ART) for HIV-1 infection and must be taken only under the supervision of a qualified healthcare professional. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice.
Always inform your doctor about your medical history, liver conditions, kidney conditions, hepatitis B status, allergies, and any medicines or supplements you take. Taftrio Tablet does not cure HIV/AIDS and should be used with regular medical follow-ups and monitoring as advised by your doctor.
Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: June 2026.
Founder, Director, and Chief Consultant, Institute of Infectious Diseases, Pune
Qualifications: MBBS, MD (Medicine), FIDSA
Experience: Over 30 years in HIV medicine, antiretroviral therapy (ART) management, drug resistance evaluation, and complex infectious diseases
Last Updated: June 2026
Taftrio Tablet is a Schedule H prescription-only antiretroviral medicine containing Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg, used as a complete antiretroviral therapy (ART) regimen for HIV-1 infection. Because this medicine may interact with other prescription medicines and require regular treatment monitoring, it should only be taken under medical supervision and exactly as prescribed by your doctor.